FEB 12, 2018 7:58 AM PST

Measles Vaccine Protects Against More Than Just the Measles

WRITTEN BY: Kara Marker

There is more to the measles vaccine than just protection from a measles infection, a new Frontiers study shows. A monumental new study of 38,000 children in Ghana reveals the importance of administering the measles vaccine at a specific time.

Histopathology of measles pneumonia. Credit: CDC

In the largest study of its kind, researchers found that the measles vaccine protects against child mortality independently of measles infections. Measles is an infection caused by a virus characterized by high fever, cough, runny nose, and red, water eyes. A vaccine to prevent measles was first developed in 1963, and now is usually given in combination with vaccines to prevent two other infections, mumps and rubella, via the MMR vaccine.

Measles is considered a childhood “killer disease,” falling alongside tuberculosis, diphtheria, tetanus, pertussis, and polio, making it apart of mass immunization programs to eliminate the virus once and for all.

In the past, studies on measles vaccination focused on when the measles vaccine was administered in relation to other vaccines. Researchers found that there was lower child mortality when the measles vaccine was given to children after the third round of the DTP3 vaccine, which protects against diphtheria, tetanus, and pertussis. This order of vaccine administration is recommended by the World Health Organization (WHO). Researchers saw this effect compared to measles vaccines given before DTP3 or with DTP3.

In the present study, researchers focused on how all-cause child mortality is affected when a child’s most recent immunization is a measles vaccine. With 38,000 children from Ghana, researchers examined survival differences between children given the measles vaccine after the DTP3 vaccine (as recommended by the WHO) and children who were not vaccinated against measles at all.

Researchers assessed survival in the first year after recording a child’s vaccination status and the again four to five years later. The study revealed that survival rates of children who received the measles vaccine increased by 28 percent in the first year after vaccination and 18 percent by the time they reach five years old, this compared to children who were not vaccinated.

This part of the result is not surprising, but the protective effect of the vaccine was not diminished when researchers excluded from the analysis the children who had died from measles, revealing the protective effects of the measles vaccine beyond prevent measles infection.

Interestingly, the protective effect of the measles vaccine was particularly evident among boys, but scientists are not yet sure why.

"Evaluations of immunization programs are usually based on the assumption that vaccines only protect against specific diseases," explained lead author Dr. Paul Welaga from the Navrongo Health Research Centre in Ghana. "Our new study adds to growing evidence that, when administered in the recommended sequence, measles vaccination helps to reduce child mortality through non-specific effects as well."

Researchers from the study plan on investigating the differences in the protective effect of the measles vaccine between males and females. Also, they plan to determine what specific benefits the vaccine provides other than preventing measles infection.

"It may be that measles infection is eliminated in the near future and thus measles vaccination is de-emphasized,” Welaga pointed out. “But if the non-specific beneficial effects of measles vaccination are indeed positive then we should consider continued vaccination even if measles is eradicated."

The present study was published in the journal Frontiers in Public Health.

Sources: Frontiers, Centers for Disease Control and Prevention

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 24, 2020
Immunology
Remember That Coronavirus You Once Met? Your T Cells Do.
SEP 24, 2020
Remember That Coronavirus You Once Met? Your T Cells Do.
The SARS-CoV-2 virus was first identified in December 2019 in Wuhan, Hubei, China and quickly escalated to a pandemic st ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
OCT 01, 2020
Immunology
Immune Cells and MS: The Good, the Bad, and the Maybe
OCT 01, 2020
Immune Cells and MS: The Good, the Bad, and the Maybe
Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a sim ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
Loading Comments...